期刊文献+

多西他赛治疗晚期头颈癌疗效观察 被引量:4

原文传递
导出
摘要 晚期头颈癌预后较差,5年生存率只有30%左右,主要治疗手段包括手术和放疗,近年来化疗在头颈癌中的作用逐渐被肯定。如何应用新的化疗方案提高晚期头颈癌的疗效是研究热点。我们应用多西他赛治疗晚期头颈癌,取得了较好疗效,现报告如下。
出处 《中国肿瘤临床与康复》 2009年第6期554-555,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
  • 相关文献

参考文献8

  • 1Schrijvers D, Vermorken JB. Taxanes in the treatment of head and neck cancer [ J ]. Curr Opin Oncol, 2005,17 ( 3 ) : 218-224.
  • 2Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(2) :74-108.
  • 3Zorat PL, Paccagnella A, Cavaniglia G, et al. Randomized phase Ⅲ trial of neoadjuvant chemotherapy in head and neck cancer: 10- year follow-up [ J ]. J Natl Cancer Inst, 2004,96 (22) : 1714- 1717.
  • 4Pignon JP, Syz N, Posner M, et al. Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck [ J ]. Anticancer Drugs,2004,15 (4) : 331-340.
  • 5Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, fluorouracil, and doeetaxel in unresectable head and neck cancer [J]. N Engl J Med,2007,357 (17) :1695-1704.
  • 6孙传政,陈福进,曾木圣,李晓江,宋立兵,李满枝,曾宗渊,陈艳峰,隋军.多西他赛单用或与顺铂联合对舌鳞癌增殖的抑制作用[J].实用癌症杂志,2006,21(5):453-457. 被引量:3
  • 7曾剑,喻庆薇,刘巍巍,曾宗渊.联合应用紫杉特尔对头颈肿瘤诱导化疗的临床病例总结[J].癌症,2003,22(8):877-879. 被引量:5
  • 8古模发,黎建军,徐国良,罗广裕,张蓉.多西他赛联合顺铂治疗鼻咽癌肝转移瘤的初步观察[J].广东医学,2005,26(11):1578-1579. 被引量:20

二级参考文献31

共引文献24

同被引文献35

  • 1古模发,黎建军,徐国良,罗广裕,张蓉.多西他赛联合顺铂治疗鼻咽癌肝转移瘤的初步观察[J].广东医学,2005,26(11):1578-1579. 被引量:20
  • 2黄健恒,李毅刚,赖素贞,刘丹婵.紫杉醇联合顺铂治疗晚期鼻咽癌临床应用[J].肿瘤研究与临床,2006,18(7):487-488. 被引量:2
  • 3洪继东,廖遇平,姜武忠,戴幼艺,袁君,周蓉蓉.多西紫杉醇联合顺铂对晚期鼻咽癌诱导化疗的近期疗效[J].中华肿瘤防治杂志,2006,13(19):1507-1508. 被引量:7
  • 4韦雄,向钟麟,李岩,唐启信.鼻咽癌常用放疗方案合理性的治疗计划系统验证分析[J].癌症,1996,15(5):366-367. 被引量:12
  • 5Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemio[ Biomarkers Prey, 2006, 15: 1765-1777.
  • 6Chua DTT, Sham JST, Au GKH, et al. Concomitant ehemo-irradiation for stage I-IV nasopharyngeal carcinoma in Chinese patients: results of a matched-cohort analysis. Int J Radiat Oncol Biol Phys, 2002, 53: 334-343.
  • 7Okiz DC, Meral G, Uzel 0, et al. Reirradiation for local recurrent nasopharyngeal carcinoma: treatment results and prognostic factors. Int Radiation Oncology Biol Phys, 2004, 60: 388-394.
  • 8Hsiung CY, Wu JM, Wang C J, et al. Attenuation of radiation dose by the skull base bone in patients with nasopharyngeal carcinoma: clinical importance.Radiology, 2001, 218: 457-463.
  • 9余更生,吕华珠,林秀欣,等.异环磷酰胺联合长春瑞滨治疗对铂类耐药的复发和/或转移性鼻咽癌月中瘤研究与临床,2006,18:246-247.
  • 10Sadamoto Zenda, Yusuke Onozawa, Narikazu Boku, et al. Single-agent docetaxel in patients with platinum-refractory metastatic or recurrentsquamous cell carcinoma of the head and neck (SCCHN). Jpn J Clin Oncol, 2007, 37: 477-481.

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部